HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Trastuzumab-based therapy has been shown to confer overall survival benefit in HER2-positive patients with advanced gastric cancer in a large multicentric trial (ToGA study). Subgroup analysis identified adenocarcinomas of the stomach and gastroesophageal (GE) junction with overexpression of HER2 ac...

詳細記述

保存先:
書誌詳細
主要な著者: Rüschoff, Josef, Dietel, Manfred, Baretton, Gustavo, Arbogast, Susanne, Walch, Axel, Monges, Geneviéve, Chenard, Marie-Pierre, Penault-Llorca, Frédérique, Nagelmeier, Iris, Schlake, Werner, Höfler, H., Kreipe, H. H.
フォーマット: Artigo
言語:Inglês
出版事項: Springer-Verlag 2010
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933810/
https://ncbi.nlm.nih.gov/pubmed/20665045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-010-0952-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料